- Recommendation ID
- IPG655
- Question
The evidence on cardiac contractility modulation device implantation for heart failure raises no major safety concerns. However, the evidence on efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research.
- Any explanatory notes
(if applicable) Further research should ideally be in the form of randomised controlled trials. These should report details of patient selection, duration and timing of stimulation, and duration of effect of stimulation. Outcomes should include ejection fraction, oxygen consumption, New York Heart Association classification and patient-reported outcomes, including quality of life.
Source guidance details
- Comes from guidance
- Cardiac contractility modulation device implantation for heart failure
- Number
- IPG655
- Date issued
- June 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | Yes |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/06/2019 |